Director, Statistical Programming

Seaport Therapeutics

2 months ago

Boston, MA

Hybrid

Full Time

Director

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

Seaport Therapeutics is a clinical-stage company developing novel neuropsychiatric medicines using its proprietary Glyph platform. The Director of Statistical Programming will build and lead the in-house Statistical Programming function within the Biometrics department, providing strategic oversight of vendor programming, performing hands-on SAS/R programming, and ensuring submission-ready, CDISC-compliant deliverables.

Skills

Qualifications

MSPhDBS

About Seaport Therapeutics

seaporttx.com

Seaport Therapeutics is a biotechnology company based in Boston developing precision therapeutics for oncology and immune‑mediated diseases. The firm leverages a proprietary discovery platform to identify and engineer targeted biologics and small molecules that modulate disease‑relevant pathways. Seaport advances programs from discovery through early clinical development and collaborates with academic and industry partners to accelerate translation. Investors and collaborators are drawn to its scientific focus on creating safer, more effective treatments for patients.

Recent company news

Business Wire

Seaport Therapeutics and Monash Institute of Pharmaceutical Sciences Awarded up to $15 Million from ARPA‑H to Advance Seaport’s GlyphCele™, the First Oral Therapeutic Designed to Restore Gut Lymphatic Function

2 weeks ago

Yahoo Finance

Seaport Therapeutics to Present at 44th Annual J.P. Morgan Healthcare Conference

Jan 5, 2026

BioSpace

Seaport Therapeutics Presents New Meta-Analysis Examining the Impact of Clinical Trial Design Factors on Placebo Response in Generalized Anxiety Disorder Trials

3 weeks ago